Literature DB >> 31322911

Update in pediatric nasopharyngeal undifferentiated carcinoma.

Line Claude1, Emmanuel Jouglar2, Loig Duverge1,3, Daniel Orbach4.   

Abstract

Many of the principles established in adults with undifferentiated nasopharyngeal carcinoma (NPC) apply to children, adolescents and young adults. However, NPC in young patients should be distinguished from the adult form by several points. This review focuses mainly on differences between adult and pediatric NPC. The role of biology and genetics in pediatric NPC is discussed. Systemic treatment modalities including type of chemotherapy induction, timing of treatment, role of immunotherapy as adjuvant treatment, or in relapsing/ metastatic diseases are reported. Radiation modalities (doses, techniques…) in children are also reviewed. Long-term effects including secondary cancers are finally be discussed in this young NPC population.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31322911      PMCID: PMC6774591          DOI: 10.1259/bjr.20190107

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  73 in total

1.  A meta-analysis of neoadjuvant chemotherapy plus radiation in the treatment of locally advanced nasopharyngeal carcinoma.

Authors:  Xun He; Kairui Xu; Jiayi Guo; Yalan Zhu; Xiaomei Liang; Lixian Liu
Journal:  J Cancer Res Ther       Date:  2015-10       Impact factor: 1.805

2.  PET/CT for staging and follow-up of pediatric nasopharyngeal carcinoma.

Authors:  Daniel K L Cheuk; Noah D Sabin; Moinul Hossain; Amy Wozniak; Mihir Naik; Carlos Rodriguez-Galindo; Matthew J Krasin; Barry L Shulkin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-04-25       Impact factor: 9.236

3.  Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.

Authors:  D T Chua; J S Sham; D Choy; V Lorvidhaya; Y Sumitsawan; S Thongprasert; V Vootiprux; A Cheirsilpa; T Azhar; A H Reksodiputro
Journal:  Cancer       Date:  1998-12-01       Impact factor: 6.860

4.  [Nasopharyngeal cancer].

Authors:  B Fleury; M C Biston; X Montbarbon; P Pommier
Journal:  Cancer Radiother       Date:  2010-11       Impact factor: 1.018

5.  Salvage regimens for pediatric patients with relapsed nasopharyngeal carcinoma.

Authors:  Christopher DeRenzo; Catherine Lam; Carlos Rodriguez-Galindo; Louis Rapkin; Stephen Gottschalk; Rajkumar Venkatramani
Journal:  Pediatr Blood Cancer       Date:  2018-10-14       Impact factor: 3.167

6.  Clinical outcome and morbidity in pediatric patients with nasopharyngeal cancer treated with chemoradiotherapy.

Authors:  Puja Sahai; Bidhu Kalyan Mohanti; Atul Sharma; Alok Thakar; Suman Bhasker; Aanchal Kakkar; Mehar Chand Sharma; Ashish Datt Upadhyay
Journal:  Pediatr Blood Cancer       Date:  2016-09-29       Impact factor: 3.167

7.  Radiation and chemotherapy combination for nasopharyngeal carcinoma in children: Radiotherapy dose adaptation after chemotherapy response to minimize late effects.

Authors:  Daniel Orbach; Hervé Brisse; Sylvie Helfre; Jerzy Klijanienko; Danielle Bours; Véronique Mosseri; José Rodriguez
Journal:  Pediatr Blood Cancer       Date:  2008-04       Impact factor: 3.167

8.  International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents.

Authors:  Michela Casanova; Enis Özyar; Catherine Patte; Daniel Orbach; Andrea Ferrari; Christine Veyrat-Follet; Hassan Errihani; Jianji Pan; Li Zhang; Liji Shen; Krzysztof J Grzegorzewski; Ali Varan
Journal:  Cancer Chemother Pharmacol       Date:  2015-12-14       Impact factor: 3.333

9.  Long-term outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinoma.

Authors:  Chang-Juan Tao; Xu Liu; Ling-Long Tang; Yan-Ping Mao; Lei Chen; Wen-Fei Li; Xiao-Li Yu; Li-Zhi Liu; Rong Zhang; Ai-Hua Lin; Jun Ma; Ying Sun
Journal:  Chin J Cancer       Date:  2013-09-10

10.  Efficacy of the Additional Neoadjuvant Chemotherapy to Concurrent Chemoradiotherapy for Patients with Locoregionally Advanced Nasopharyngeal Carcinoma: a Bayesian Network Meta-analysis of Randomized Controlled Trials.

Authors:  Yu-Pei Chen; Rui Guo; Na Liu; Xu Liu; Yan-Ping Mao; Ling-Long Tang; Guan-Qun Zhou; Ai-Hua Lin; Ying Sun; Jun Ma
Journal:  J Cancer       Date:  2015-07-17       Impact factor: 4.207

View more
  6 in total

1.  Advances in nasopharyngeal carcinoma-"West meets East".

Authors:  Melvin Lk Chua; Ying Sun; Stéphane Supiot
Journal:  Br J Radiol       Date:  2019-10       Impact factor: 3.039

Review 2.  Epidemiology and treatment of head and neck malignancies in the AYA generation.

Authors:  Takahiro Asakage
Journal:  Int J Clin Oncol       Date:  2022-01-14       Impact factor: 3.402

3.  Comparison of Prognosis Between Juvenile and Adult Nasopharyngeal Carcinoma: A Propensity Score-Matched Analysis.

Authors:  Chuanben Chen; Qinyan Chen; Yuanji Xu; Wei Zheng; Zhizhong Lin; Zijie Wu; Wangzhong Ye; Xinyi Huang; Xiurong Lin; Penggang Bai
Journal:  Cancer Manag Res       Date:  2020-09-18       Impact factor: 3.989

4.  Convolutional Neural Network Intelligent Segmentation Algorithm-Based Magnetic Resonance Imaging in Diagnosis of Nasopharyngeal Carcinoma Foci.

Authors:  Deli Wang; Zheng Gong; Yanfen Zhang; Shouxi Wang
Journal:  Contrast Media Mol Imaging       Date:  2021-08-13       Impact factor: 3.161

5.  Influence of Tumor Site on Survival in Young Patients with Head and Neck Squamous Cell Carcinoma.

Authors:  Claudius Steffen; Iris Piwonski; Max Heiland; Carmen Stromberger; Grzegorz Kofla; Christian Doll; Annekatrin Coordes; Benedicta Beck-Broichsitter
Journal:  Curr Oncol       Date:  2022-02-10       Impact factor: 3.677

6.  Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma.

Authors:  Sung-Wei Lee; Ching-Chieh Yang; Hong-Yue Lai; Hsin-Hwa Tsai; Cheng-Fa Yeh; Yu-Hsuan Kuo; Nai-Wen Kang; Tzu-Ju Chen; Shih-Lun Chang
Journal:  Clin Med Insights Oncol       Date:  2022-07-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.